Rituximab and factors predictive of response in chronic immune thrombocytopenic purpura of children.
Cesaro
Simone
S
Bisogno
Gianni
G
Pusiol
Anna
A
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived; D018941:Antigens, CD19 / Q000187:drug effects*; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000172:deficiency* / Q000187:drug effects; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018941:Antigens, CD19; D007136:Immunoglobulins; D000069283:Rituximab